PDGFRB and melanoma: Nazarian et al. [37] observed that by silencing PDGFRβ expression in BRAFV600E-inhibited melanoma cells, restoration of the apoptotic pathways in these cells did not occur, indicating that the upregulation of this growth factor receptor was not the only mechanism of resistance.